{"title":"蛋白质的驯化——从进化到革命","authors":"John van der Oost","doi":"10.1111/1751-7915.13987","DOIUrl":null,"url":null,"abstract":"<p>In the course of natural evolution, an overwhelming diversity of proteins has emerged. Collectively, these proteins are responsible for a wide range of biological functions that, in one way or another, support live. Billions of years of natural selection have resulted in survival of the fittest protein variants that function appropriately in the context of a biological entity. When using these proteins for biotechnology applications, however, it is often required to improve their performance, because of distinct conditions (<i>in vitro</i>, <i>ex vivo</i>, <i>in vivo</i>) and different demands (activity, specificity, stability).</p><p>Hence, repurposing natural proteins for biotechnological applications generally requires domestication, aiming at optimising their functionality by adjusting their amino acid sequence. Rational engineering approaches aim at specifically substituting one or more amino acid residues by engineering of the corresponding gene. Rational design obviously requires a relatively high level of understanding of structural and functional features of the protein of interest. In case insights are lacking on how to rationally improve a certain protein's functionality, laboratory evolution is an attractive alternative. The impact of laboratory evolution in optimising proteins is reflected by the Nobel Prize in Chemistry 2018, awarded to Frances H. Arnold, George P. Smith, and Gregory P. Winter.</p><p>Like natural evolution, laboratory evolution is based on repeated cycles of genetic variation, expression and selection (Stemmer, <span>1994</span>; Arnold, <span>2018</span>). To allow tracing a protein variant with a desired functionality back to its gene, a genotype-to-phenotype linkage is a key requirement. This can be achieved either by physically linking the gene and gene-encoded product (DNA display, mRNA display, ribosome display), or by compartmentalising the gene and the corresponding protein within the same physical space (reviewed by Bouzetos et al., <span>2021</span>). Unicellular microorganisms (e.g. <i>E</i>. <i>coli</i>) or viral particles (e.g. M13) are often used as biological micro-compartments.</p><p>Despite spectacular technical and biochemical progress, laboratory evolution systems are often technically challenging. Successful applications rely on efficient genetic variation, robust protein production, and smart screening/selection of improved variants. In addition, especially in case of huge libraries (a million variants or more), the process can be rather laborious and/or expensive. A spectacular development concerns a Phage-Assisted Continuous Evolution system (Esvelt et al., <span>2011</span>). In this PACE approach, M13 phages carry a gene encoding a protein-of-interest that controls the production of functional phage particles in a mutator <i>E</i>. <i>coli</i> host. The fitness of released M13 particles directly correlates with the fitness of the protein-of-interest. Within a couple of days, many cycles of error-prone replication and in situ selection have occurred with minimal human intervention, like an <i>in vivo</i> PCR reaction. To date, the PACE system has mainly been used to optimise DNA-binding proteins. To allow for optimisation of other enzymes, a prototype for a smart screening/selection system has been established by using an <i>E. coli</i> cell equipped with a specific signal transduction pathway that couples the enzyme-based generation of a product to the growth/survival of the bacterial clone (Van Sint Fiet et al., <span>2006</span>).</p><p>Another ground-breaking development in laboratory evolution concerns the use of non-biological compartments to maintain the genotype-and-phenotype link. Microtiter plates have frequently been used for this purpose. However, when high-throughput analysis of large libraries is required, <i>in vitro</i> compartmentalisation (IVC) seems a better choice (Tawfik and Griffiths <span>1998</span>). In IVC, single gene variants of a library are engulfed in artificial compartments such as water-in-oil droplets, or water-in-oil-in-water droplets. Recent progress in microfluidic technology has allowed for the production of highly monodisperse droplets (reviewed by Bouzetos et al., <span>2021</span>). Gene expression inside these artificial compartment is catalysed by <i>in vitro</i> transcription and translation systems. Again, linking genotype and phenotype allows for enriching the genes encoding well-performing enzyme variants. In case of general enzymes, this requires a covalent link of the enzyme's substrate and the enzyme-encoding gene, which may be technically challenging; in case of DNA-targeting enzymes this is straightforward: the nuclease gene and its target can easily be combined on a single synthetic DNA fragment.</p><p>The combination of evolution principles with the emerging technologies will be extremely powerful. Hence, efficiencies should be improved at all levels: generation of genetic libraries, compartmentalisation, and last but not least smart screening or selection approaches. Especially major recent developments of both microfluidics technology and of high-throughput automated sorting methods of cells or droplets (FACS/FADS) hold promise for unprecedented possibilities in the (near) future to obtain proteins with desired optimal features (reviewed by Bouzetos et al., <span>2021</span>). As Charles Darwin stated: ‘There is grandeur in this view of life, (…) from so simple a beginning endless forms most beautiful and wonderful have been and are being evolved’. This is not only true for biological creatures, but certainly also for their proteins. Hence, expectations for the future are high: from evolution to revolution!</p><p>None declared.</p><p>No funding information provided.</p>","PeriodicalId":49145,"journal":{"name":"Microbial Biotechnology","volume":"15 1","pages":"189-190"},"PeriodicalIF":4.8000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13987","citationCount":"0","resultStr":"{\"title\":\"Domestication of proteins – from evolution to revolution\",\"authors\":\"John van der Oost\",\"doi\":\"10.1111/1751-7915.13987\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In the course of natural evolution, an overwhelming diversity of proteins has emerged. Collectively, these proteins are responsible for a wide range of biological functions that, in one way or another, support live. Billions of years of natural selection have resulted in survival of the fittest protein variants that function appropriately in the context of a biological entity. When using these proteins for biotechnology applications, however, it is often required to improve their performance, because of distinct conditions (<i>in vitro</i>, <i>ex vivo</i>, <i>in vivo</i>) and different demands (activity, specificity, stability).</p><p>Hence, repurposing natural proteins for biotechnological applications generally requires domestication, aiming at optimising their functionality by adjusting their amino acid sequence. Rational engineering approaches aim at specifically substituting one or more amino acid residues by engineering of the corresponding gene. Rational design obviously requires a relatively high level of understanding of structural and functional features of the protein of interest. In case insights are lacking on how to rationally improve a certain protein's functionality, laboratory evolution is an attractive alternative. The impact of laboratory evolution in optimising proteins is reflected by the Nobel Prize in Chemistry 2018, awarded to Frances H. Arnold, George P. Smith, and Gregory P. Winter.</p><p>Like natural evolution, laboratory evolution is based on repeated cycles of genetic variation, expression and selection (Stemmer, <span>1994</span>; Arnold, <span>2018</span>). To allow tracing a protein variant with a desired functionality back to its gene, a genotype-to-phenotype linkage is a key requirement. This can be achieved either by physically linking the gene and gene-encoded product (DNA display, mRNA display, ribosome display), or by compartmentalising the gene and the corresponding protein within the same physical space (reviewed by Bouzetos et al., <span>2021</span>). Unicellular microorganisms (e.g. <i>E</i>. <i>coli</i>) or viral particles (e.g. M13) are often used as biological micro-compartments.</p><p>Despite spectacular technical and biochemical progress, laboratory evolution systems are often technically challenging. Successful applications rely on efficient genetic variation, robust protein production, and smart screening/selection of improved variants. In addition, especially in case of huge libraries (a million variants or more), the process can be rather laborious and/or expensive. A spectacular development concerns a Phage-Assisted Continuous Evolution system (Esvelt et al., <span>2011</span>). In this PACE approach, M13 phages carry a gene encoding a protein-of-interest that controls the production of functional phage particles in a mutator <i>E</i>. <i>coli</i> host. The fitness of released M13 particles directly correlates with the fitness of the protein-of-interest. Within a couple of days, many cycles of error-prone replication and in situ selection have occurred with minimal human intervention, like an <i>in vivo</i> PCR reaction. To date, the PACE system has mainly been used to optimise DNA-binding proteins. To allow for optimisation of other enzymes, a prototype for a smart screening/selection system has been established by using an <i>E. coli</i> cell equipped with a specific signal transduction pathway that couples the enzyme-based generation of a product to the growth/survival of the bacterial clone (Van Sint Fiet et al., <span>2006</span>).</p><p>Another ground-breaking development in laboratory evolution concerns the use of non-biological compartments to maintain the genotype-and-phenotype link. Microtiter plates have frequently been used for this purpose. However, when high-throughput analysis of large libraries is required, <i>in vitro</i> compartmentalisation (IVC) seems a better choice (Tawfik and Griffiths <span>1998</span>). In IVC, single gene variants of a library are engulfed in artificial compartments such as water-in-oil droplets, or water-in-oil-in-water droplets. Recent progress in microfluidic technology has allowed for the production of highly monodisperse droplets (reviewed by Bouzetos et al., <span>2021</span>). Gene expression inside these artificial compartment is catalysed by <i>in vitro</i> transcription and translation systems. Again, linking genotype and phenotype allows for enriching the genes encoding well-performing enzyme variants. In case of general enzymes, this requires a covalent link of the enzyme's substrate and the enzyme-encoding gene, which may be technically challenging; in case of DNA-targeting enzymes this is straightforward: the nuclease gene and its target can easily be combined on a single synthetic DNA fragment.</p><p>The combination of evolution principles with the emerging technologies will be extremely powerful. Hence, efficiencies should be improved at all levels: generation of genetic libraries, compartmentalisation, and last but not least smart screening or selection approaches. Especially major recent developments of both microfluidics technology and of high-throughput automated sorting methods of cells or droplets (FACS/FADS) hold promise for unprecedented possibilities in the (near) future to obtain proteins with desired optimal features (reviewed by Bouzetos et al., <span>2021</span>). As Charles Darwin stated: ‘There is grandeur in this view of life, (…) from so simple a beginning endless forms most beautiful and wonderful have been and are being evolved’. This is not only true for biological creatures, but certainly also for their proteins. Hence, expectations for the future are high: from evolution to revolution!</p><p>None declared.</p><p>No funding information provided.</p>\",\"PeriodicalId\":49145,\"journal\":{\"name\":\"Microbial Biotechnology\",\"volume\":\"15 1\",\"pages\":\"189-190\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sfamjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.13987\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbial Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13987\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-7915.13987","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
在自然进化过程中,出现了种类繁多的蛋白质。总的来说,这些蛋白质负责各种各样的生物功能,以这样或那样的方式维持生命。数十亿年的自然选择导致了最适合的蛋白质变体的生存,这些变体在生物实体的环境中发挥着适当的作用。然而,当将这些蛋白质用于生物技术应用时,由于不同的条件(体外、离体、体内)和不同的要求(活性、特异性、稳定性),通常需要提高它们的性能。因此,将天然蛋白质重新用于生物技术应用通常需要驯化,旨在通过调整其氨基酸序列来优化其功能。合理的工程方法旨在通过工程改造相应的基因来特异性地取代一个或多个氨基酸残基。合理的设计显然需要对感兴趣的蛋白质的结构和功能特征有较高的理解。如果缺乏对如何合理地改善某种蛋白质功能的见解,实验室进化是一个有吸引力的选择。2018年诺贝尔化学奖授予弗朗西丝·h·阿诺德、乔治·p·史密斯和格雷戈里·p·温特,这反映了实验室进化在优化蛋白质方面的影响。与自然进化一样,实验室进化是基于基因变异、表达和选择的重复循环(Stemmer, 1994;阿诺德,2018)。为了将具有期望功能的蛋白质变体追溯到其基因,基因型与表型的联系是一个关键要求。这可以通过物理连接基因和基因编码产物(DNA显示、mRNA显示、核糖体显示),或通过在同一物理空间内划分基因和相应的蛋白质来实现(Bouzetos et al., 2021)。单细胞微生物(如大肠杆菌)或病毒颗粒(如M13)常被用作生物微室。尽管在技术和生化方面取得了惊人的进步,但实验室进化系统在技术上往往具有挑战性。成功的应用依赖于有效的遗传变异,强大的蛋白质生产和智能筛选/选择改进的变体。此外,特别是在大型库(一百万个变体或更多)的情况下,该过程可能相当费力和/或昂贵。一个引人注目的发展涉及噬菌体辅助连续进化系统(Esvelt et al., 2011)。在这种PACE方法中,M13噬菌体携带一种基因,编码一种目标蛋白,该蛋白控制突变大肠杆菌宿主中功能性噬菌体颗粒的产生。释放的M13粒子的适合度与目标蛋白的适合度直接相关。在几天内,许多容易出错的复制和原位选择周期在最小的人为干预下发生,就像体内PCR反应一样。迄今为止,PACE系统主要用于优化dna结合蛋白。为了优化其他酶,已经建立了智能筛选/选择系统的原型,通过使用配备特定信号转导途径的大肠杆菌细胞,将基于酶的产物生成与细菌克隆的生长/存活结合起来(Van Sint Fiet et al., 2006)。实验室进化的另一个突破性发展涉及使用非生物区室来维持基因型和表型的联系。微量滴度板经常用于这一目的。然而,当需要对大型文库进行高通量分析时,体外区隔化(IVC)似乎是更好的选择(Tawfik和Griffiths 1998)。在IVC中,文库的单基因变异被吞没在人工隔间中,如油中水滴或油中水滴。微流体技术的最新进展使生产高度单分散的液滴成为可能(Bouzetos等人,2021年进行了综述)。这些人工隔室内的基因表达由体外转录和翻译系统催化。再一次,将基因型和表型联系起来,可以丰富编码性能良好的酶变体的基因。在一般酶的情况下,这需要酶的底物和酶编码基因的共价连接,这在技术上可能具有挑战性;在DNA靶向酶的情况下,这很简单:核酸酶基因和它的目标可以很容易地结合在一个单一的合成DNA片段上。进化原理与新兴技术的结合将是非常强大的。因此,应该在所有层面上提高效率:遗传文库的生成,划分,以及最后但并非最不重要的智能筛选或选择方法。 特别是微流体技术和细胞或液滴的高通量自动分选方法(FACS/FADS)的最新重大发展,为(近期)将来获得具有所需最佳特征的蛋白质提供了前所未有的可能性(Bouzetos等人,2021年进行了综述)。正如查尔斯·达尔文所说:“对生命的这种看法是伟大的,(……)从如此简单的开始,无数最美丽、最奇妙的形式已经和正在进化。”这不仅适用于生物,当然也适用于它们的蛋白质。因此,对未来的期望很高:从进化到革命!没有宣布。没有提供供资资料。
Domestication of proteins – from evolution to revolution
In the course of natural evolution, an overwhelming diversity of proteins has emerged. Collectively, these proteins are responsible for a wide range of biological functions that, in one way or another, support live. Billions of years of natural selection have resulted in survival of the fittest protein variants that function appropriately in the context of a biological entity. When using these proteins for biotechnology applications, however, it is often required to improve their performance, because of distinct conditions (in vitro, ex vivo, in vivo) and different demands (activity, specificity, stability).
Hence, repurposing natural proteins for biotechnological applications generally requires domestication, aiming at optimising their functionality by adjusting their amino acid sequence. Rational engineering approaches aim at specifically substituting one or more amino acid residues by engineering of the corresponding gene. Rational design obviously requires a relatively high level of understanding of structural and functional features of the protein of interest. In case insights are lacking on how to rationally improve a certain protein's functionality, laboratory evolution is an attractive alternative. The impact of laboratory evolution in optimising proteins is reflected by the Nobel Prize in Chemistry 2018, awarded to Frances H. Arnold, George P. Smith, and Gregory P. Winter.
Like natural evolution, laboratory evolution is based on repeated cycles of genetic variation, expression and selection (Stemmer, 1994; Arnold, 2018). To allow tracing a protein variant with a desired functionality back to its gene, a genotype-to-phenotype linkage is a key requirement. This can be achieved either by physically linking the gene and gene-encoded product (DNA display, mRNA display, ribosome display), or by compartmentalising the gene and the corresponding protein within the same physical space (reviewed by Bouzetos et al., 2021). Unicellular microorganisms (e.g. E. coli) or viral particles (e.g. M13) are often used as biological micro-compartments.
Despite spectacular technical and biochemical progress, laboratory evolution systems are often technically challenging. Successful applications rely on efficient genetic variation, robust protein production, and smart screening/selection of improved variants. In addition, especially in case of huge libraries (a million variants or more), the process can be rather laborious and/or expensive. A spectacular development concerns a Phage-Assisted Continuous Evolution system (Esvelt et al., 2011). In this PACE approach, M13 phages carry a gene encoding a protein-of-interest that controls the production of functional phage particles in a mutator E. coli host. The fitness of released M13 particles directly correlates with the fitness of the protein-of-interest. Within a couple of days, many cycles of error-prone replication and in situ selection have occurred with minimal human intervention, like an in vivo PCR reaction. To date, the PACE system has mainly been used to optimise DNA-binding proteins. To allow for optimisation of other enzymes, a prototype for a smart screening/selection system has been established by using an E. coli cell equipped with a specific signal transduction pathway that couples the enzyme-based generation of a product to the growth/survival of the bacterial clone (Van Sint Fiet et al., 2006).
Another ground-breaking development in laboratory evolution concerns the use of non-biological compartments to maintain the genotype-and-phenotype link. Microtiter plates have frequently been used for this purpose. However, when high-throughput analysis of large libraries is required, in vitro compartmentalisation (IVC) seems a better choice (Tawfik and Griffiths 1998). In IVC, single gene variants of a library are engulfed in artificial compartments such as water-in-oil droplets, or water-in-oil-in-water droplets. Recent progress in microfluidic technology has allowed for the production of highly monodisperse droplets (reviewed by Bouzetos et al., 2021). Gene expression inside these artificial compartment is catalysed by in vitro transcription and translation systems. Again, linking genotype and phenotype allows for enriching the genes encoding well-performing enzyme variants. In case of general enzymes, this requires a covalent link of the enzyme's substrate and the enzyme-encoding gene, which may be technically challenging; in case of DNA-targeting enzymes this is straightforward: the nuclease gene and its target can easily be combined on a single synthetic DNA fragment.
The combination of evolution principles with the emerging technologies will be extremely powerful. Hence, efficiencies should be improved at all levels: generation of genetic libraries, compartmentalisation, and last but not least smart screening or selection approaches. Especially major recent developments of both microfluidics technology and of high-throughput automated sorting methods of cells or droplets (FACS/FADS) hold promise for unprecedented possibilities in the (near) future to obtain proteins with desired optimal features (reviewed by Bouzetos et al., 2021). As Charles Darwin stated: ‘There is grandeur in this view of life, (…) from so simple a beginning endless forms most beautiful and wonderful have been and are being evolved’. This is not only true for biological creatures, but certainly also for their proteins. Hence, expectations for the future are high: from evolution to revolution!
期刊介绍:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes